...
首页> 外文期刊>Hepato-gastroenterology. >Multivariate analysis of prognostic factors in 549 patients undergoing surgical treatment of gastric cancer.
【24h】

Multivariate analysis of prognostic factors in 549 patients undergoing surgical treatment of gastric cancer.

机译:549例接受胃癌手术治疗的患者的预后因素多因素分析。

获取原文
获取原文并翻译 | 示例
           

摘要

Gastric cancer is a common malignancy with high mortality rate, and surgical resection is the primary treatment.A retrospective analysis of patients who received surgical treatment for primary gastric cancer from January 2006 to December 2010 was performed. Cox univariate and multivariate analyses were performed to determine factors associated with decreased survival.A total of 549 patients were included in the analysis (421 men and 128 women) with a mean age of 59.5 years (range, 21-81 years). Radical resection was performed in 496 patients, including D1 resection in 72 cases (14.5%), D2 resection in 380 cases (76.6%), and D3 resection in 44 cases (8.9%). The follow-up ranged from 3 to 67 months, during which 368 patients were alive or censored and 181 patients died. The overall 6-month and 1-, 3-, and 5-years survival rates were 89.8%, 80.8%, 58.9%, and 49.7% respectively. Multivariate analysis indicated that tumor size > 5 cm, increasing TNM stage, no resection, receiving perioperative blood transfusion, serum albumin <37 g/L, and not receiving postoperative comprehensive treatment (Chinese medicine, chemotherapy, immunotherapy) were associated with decreased survival.Tumor size, TNM stage, extent of resection, serum albumin level, and comprehensive treatment were important prognostic factors.
机译:胃癌是高死亡率的常见恶性肿瘤,手术切除是主要治疗方法。对2006年1月至2010年12月接受手术治疗的原发性胃癌患者进行回顾性分析。进行Cox单变量和多变量分析以确定与生存率降低相关的因素。该分析共纳入549例患者(421名男性和128名女性),平均年龄为59.5岁(范围为21-81岁)。 496例行根治性切除,其中D1切除72例(14.5%),D2切除380例(76.6%),D3切除44例(8.9%)。随访时间从3个月到67个月不等,在此期间,有368位患者活着或受到检查,有181位患者死亡。 6个月,1年,3年和5年的总生存率分别为89.8%,80.8%,58.9%和49.7%。多因素分析表明,肿瘤大小> 5 cm,TNM分期增加,未切除,围手术期输血,血清白蛋白<37 g / L,未接受术后综合治疗(中药,化学疗法,免疫疗法)与生存率降低相关。肿瘤大小,TNM分期,切除范围,血清白蛋白水平和综合治疗是重要的预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号